Alembic Pharmaceuticals Limited has informed the Exchange about change in Management
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alembic Pharmaceuticals has appointed Mr. Jigr Shah as Head - Business Finance, a Senior Management Personnel role, effective 15th May 2025 on a full-time basis. He brings 20+ years of business finance experience across India and emerging markets, with prior stints at Dr. Reddy's Laboratories (Vietnam), Mega Lifesciences (Vietnam), ITC, and Ernst & Young, and a Deloitte internship. The role focuses on financial strategy, ABAC/SOXX compliance, and evaluating strategic growth initiatives. This is a senior management addition with no changes to the board, CEO, or CFO positions.
This is a routine operational-level senior management appointment and is unlikely to materially affect the stock price or shareholder value. Investors can treat it as a standard staffing update with no governance or leadership signal.